118 related articles for article (PubMed ID: 7715618)
21. Hypoxia-dependent retinal toxicity of bioreductive anticancer prodrugs in mice.
Lee AE; Wilson WR
Toxicol Appl Pharmacol; 2000 Feb; 163(1):50-9. PubMed ID: 10662604
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
Fracasso PM; Sartorelli AC
Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
[TBL] [Abstract][Full Text] [Related]
23. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine.
Olive PL
Br J Cancer; 1995 Mar; 71(3):529-36. PubMed ID: 7880735
[TBL] [Abstract][Full Text] [Related]
24. Toxicology of daily administration to mice of the radiation potentiator SR 4233 (WIN 59075).
Spiegel JF; Spear MA; Brown JM
Radiother Oncol; 1993 Jan; 26(1):79-81. PubMed ID: 8438092
[TBL] [Abstract][Full Text] [Related]
25. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
26. Use of the comet assay to detect hypoxic cells in murine tumours and normal tissues exposed to bioreductive drugs.
Olive PL
Acta Oncol; 1995; 34(3):301-5. PubMed ID: 7779413
[TBL] [Abstract][Full Text] [Related]
27. [Significance of formation of micronuclei in SCC VII murine cells treated with various chemotherapeutic agents].
Jeremić B; Sibamoto J; Abe M
Srp Arh Celok Lek; 1996; 124(7-8):169-74. PubMed ID: 9102841
[TBL] [Abstract][Full Text] [Related]
28. Reoxygenation and rehypoxiation in the SCCVII mouse tumor.
Kim IH; Brown JM
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):493-7. PubMed ID: 8005805
[TBL] [Abstract][Full Text] [Related]
29. Bioreductive drugs and the selective induction of tumour hypoxia.
Bremner JC; Stratford IJ; Bowler J; Adams GE
Br J Cancer; 1990 May; 61(5):717-21. PubMed ID: 2110814
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of SR 4233-induced hepatocyte toxicity under aerobic versus hypoxic conditions.
Silva JM; O'Brien PJ
Br J Cancer; 1993 Sep; 68(3):484-91. PubMed ID: 8394729
[TBL] [Abstract][Full Text] [Related]
31. Physiologic and cytotoxic effects of tirapazamine in tumor-bearing mice.
Durand RE; Olive PL
Radiat Oncol Investig; 1997; 5(5):213-9. PubMed ID: 9372543
[TBL] [Abstract][Full Text] [Related]
32. Use of the cytokinesis-block micronucleus method in mouse splenocytes.
Ren L; Yang JP; Zhang HX
Mutat Res; 1991 Feb; 262(2):119-24. PubMed ID: 1900351
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of bioreductive drugs in multicell spheroids.
Durand RE; Olive PL
Int J Radiat Oncol Biol Phys; 1992; 22(4):689-92. PubMed ID: 1544838
[TBL] [Abstract][Full Text] [Related]
34. Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro.
Keyes SR; Rockwell S; Sartorelli AC
Cancer Res; 1985 Aug; 45(8):3642-5. PubMed ID: 3926306
[TBL] [Abstract][Full Text] [Related]
35. Hypobaric hypoxia: a method for testing bioreductive drugs in vivo.
McAleer JJ; McKeown SR; MacManus MP; Lappin TR; Bridges JM
Int J Radiat Oncol Biol Phys; 1992; 23(3):551-5. PubMed ID: 1612955
[TBL] [Abstract][Full Text] [Related]
36. Use of the cytokinesis-block method for the analysis of micronuclei in V79 Chinese hamster lung cells: results with mitomycin C and cyclophosphamide.
Krishna G; Kropko ML; Theiss JC
Mutat Res; 1989 Jan; 222(1):63-9. PubMed ID: 2492079
[TBL] [Abstract][Full Text] [Related]
37. Relationships among micronuclei, nucleoplasmic bridges and nuclear buds within individual cells in the cytokinesis-block micronucleus assay.
Cheong HS; Seth I; Joiner MC; Tucker JD
Mutagenesis; 2013 Jul; 28(4):433-40. PubMed ID: 23702692
[TBL] [Abstract][Full Text] [Related]
38. Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin.
Koch CJ
Cancer Res; 1993 Sep; 53(17):3992-7. PubMed ID: 8358728
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of oncogenicity for bioreductive drugs.
Hei TK; Piao CQ; He ZY; Hall EJ
Int J Radiat Oncol Biol Phys; 1992; 22(4):747-50. PubMed ID: 1544847
[TBL] [Abstract][Full Text] [Related]
40. Cellular approaches to bioreductive drug mechanisms.
Rauth AM; Marshall RS; Kuehl BL
Cancer Metastasis Rev; 1993 Jun; 12(2):153-64. PubMed ID: 8375018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
